Trial Profile
To investigate the mechanisms underpinning the modulation of spastic hypertonia by Sativex, at both central and spinal levels, through an extensive neurophysiological battery in patients with Multiple sclerosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2017
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 09 Jun 2017 New trial record